Conflict of interest: Authors declare that there is no potential conflict of interest.
Modification of risk, but not survival of esophageal cancer patients by esophageal cancer-related gene 1 Arg290Gln polymorphism: A case–control study and meta-analysis
Article first published online: 22 OCT 2013
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd
Journal of Gastroenterology and Hepatology
Volume 28, Issue 11, pages 1717–1724, November 2013
How to Cite
Umar, M., Upadhyay, R., Kumar, S., Ghoshal, U. C. and Mittal, B. (2013), Modification of risk, but not survival of esophageal cancer patients by esophageal cancer-related gene 1 Arg290Gln polymorphism: A case–control study and meta-analysis. Journal of Gastroenterology and Hepatology, 28: 1717–1724. doi: 10.1111/jgh.12335
- Issue published online: 22 OCT 2013
- Article first published online: 22 OCT 2013
- Accepted manuscript online: 22 JUL 2013 05:11AM EST
- Manuscript Accepted: 1 JUL 2013
- Indian Council of Medical Research (ICMR)
Table S1 Role of ECRG1 Arg290Gln on survival outcome of esophageal cancer patients in separate treatment groups (radiotherapy alone or radiotherapy along with chemotherapy).
Table S2 Distribution of ECRG1 Arg290Gln polymorphism among patients with different clinicopathological variables.
Table S3 Effect of clinicopathological variables on the prognosis of esophageal cancer (EC).
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.